Eurolen 5 mg. 10 mg. 15 mg & 25 mg Hard capsules
PDF Leaflet Revision Date: 27 November 2020
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of myelodysplastic syndromes and multiple myeloma.
Dosage (summary)
MDS: 10 mg orally once daily for 21 days in 28-day cycles. MM: 25 mg orally once daily for 21 days in 28-day cycles.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; teratogenic effects expected. Not recommended during breastfeeding.
Key Drug Interactions
- Increased risk of thromboembolism with dexamethasone
- Caution with erythropoietic agents
Contraindications
- Hypersensitivity to lenalidomide
- Pregnancy
- Lactation
Common side effects
- Neutropenia
- Thrombocytopenia
- Venous thromboembolism
- Fatigue
- Dizziness
Counselling Points
- Use effective contraception
- Report signs of infection
- Monitor for signs of thromboembolism
Serious warnings
- Severe birth defects
- Myocardial infarction risk
- Severe skin reactions
Important Disclaimer
The Eurolen 5 mg. 10 mg. 15 mg & 25 mg Hard capsules professional information leaflet below is the property of Eurolab _ and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
